Sweta Subhadarshani is a Dermatology physician affiliated with Thomas Jefferson University. OpenAlex indexes 50 publications with 212 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
Philadelphia, PA 191044206
Telephone
215-662-2737Provider last certified this registry record 16 Apr 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20254 payments
- Janssen Biotech, Inc.Program year20251 payment
- Helsinn Therapeutics (U.S.), Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
33.3%Corticosteroid18.3%Triamcinolone Acetonide70%Fluocinolone Acetonide30%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist10%Dupixent Pen100%Part D<11 patients+ 1 more class in this area
Sensory organs
31.5%Corticosteroid31.5%Clobetasol Propionate100%Part D≥38 patientsAnti-infectives
25.6%Azole Antifungal10%Ketoconazole100%Part D≥16 patientsTetracycline-class Drug7.8%Doxycycline Monohydrate100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessment of Thromboembolic Events in Juvenile Dermatomyositis Patients Receiving IVIG Therapy
Journal of Investigative Dermatology
2026 - Cutaneous vasculopathy in autoimmune connective tissue diseases: Need for a standardized evaluation tool
Journal of the American Academy of Dermatology
2026 - 75906 Clinical Profile of Adult Patients with Erythromelalgia
Journal of the American Academy of Dermatology
2026 - Beyond Classical STIs: Emerging Non-Traditional Sexually Transmissible Pathogens in Modern Sexual Networks
Journal of the American Academy of Dermatology
2026 - 76834 Effect of Biologics on Cardiovascular Event Risk in Dermatomyositis: A Propensity-Matched Analysis
Journal of the American Academy of Dermatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”